-
Notifications
You must be signed in to change notification settings - Fork 1
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Homogenize "Subject" Nomenclature #14
Comments
@tsalo thank you for bringing this up. While the urgency from my side (and that of other preclinical researchers using SAMRI) has decreased following our begrudging adoption of this element of the standard, I would again recommend this as a worthwhile change. |
I agree with this point, just brought this up with @Remi-Gau who pointed me to this issue (thanks!). |
In the light of the BEP032 (attn @bids-standard/bep032 and here #38) for animal ephys |
just for info, "sample" is already used in BIDS (for pre-clinical research, i.e to specify that several "samples", e.g tissue slices, can be extracted from the same "subject" (animal)... |
FTR, another definitely non-participant'y and even overall inanimate use-case came up yesterday in so there "subject" IMHO still works as (inanimate) "subject of study". |
We are currently using the terms “participant” and “subject” interchangeably. I propose we make the names homogeneous. In order to afford better extendability with preclinical research, the term “subject” would be significantly more apt.
GitHub Issue: bids-standard/bids-specification#384
This change would include renaming the
participants.tsv
file tosubjects.tsv
, and theparticipant_id
column in said file tosubject
.Original authors: @TheChymera
The text was updated successfully, but these errors were encountered: